1mg, best e pharmacy in India




Arformoterol is used in the treatment of asthma and chronic obstructive pulmonary disorder (copd).

How it works

The Arformoterol works by relaxing the muscles in the walls of the airways. This opens the airways and makes breathing easier.

Common side effects

Rash, Headache, Dizziness, Back pain, Increased white blood cell count, Facial swelling, Increased potassium level in blood, Shortness of breath, Insomnia (difficulty in sleeping), Vomiting, Nausea, Oropharyngeal pain, Nasopharyngitis, Irregular heart rate, Diarrhoea, Tachycardia, Difficulty in swalloing, Cough, Abdominal bloating, Chest pain, Urticaria, Nervousness, Tremor

Available Medicine

No medicine available

Expert advice

  • Inform you doctor if you are taking other inhalation or oral long-acting beta2-agonists.
  • If you have been taking short-acting beta2-agonists on a regular basis (4 times a day), discontinue the use of these drugs when beginning treatment with arformoterol.
  • Arformoterol does not quickly relieve breathing problems.
  • Use short-acting beta2-agonists, as required only to attain immediate relief of breathlessness, on an as required basis.
  • Do not use arformoterol to relieve symptoms of asthma as it may increase the risk of asthma-related deaths.
  • Avoid long term use of arformoterol as it can cause paradoxical bronchospasm.
  • Inform your doctor if you have cardiovascular disorders like coronary insufficiency, cardiac arrhythmias, and hypertension.
  • Tell your doctor if you are or planning to become pregnant or are breastfeeding.

Frequently asked questions



What is arformoterol tartrate?
Arformoterol tartrate is a salt form and it is a long-acting beta agonist (LABA). It works by relaxing and opening constricted air passages in the lungs, making it easier to breathe


What is arformoterol used for?
Arformoterol is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disorder (COPD), a lung disorder in which flow of air to the lung is blocked.

Content on this page was last updated on 13 February, 2017, by Dr. Varun Gupta (MD Pharmacology)